Systematic analysis reveals tumor-enhancing and -suppressing microRNAs in Drosophila epithelial tumors

Zhiqiang Shu1, Yi-Chun Huang1, William H Palmer1,2

  • 1Department of Biological Science, Florida State University, Tallahassee, Florida, USA.

Oncotarget
|January 10, 2018
PubMed

Insights

MicroRNAs (miRNAs) play a role in cancer, but their exact function in tumor formation is unclear. This study identified specific tumor-enhancing and tumor-suppressing miRNAs in Drosophila, offering potential therapeutic targets for epithelial tumors.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are noncoding RNAs implicated in cancer progression, yet their specific roles in tumorigenesis require further elucidation.
  • Understanding miRNA involvement in primary tumor formation is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the functional roles of microRNAs in epithelial tumorigenesis using a Drosophila model.
  • To identify specific microRNAs that enhance or suppress tumor formation induced by neoplastic tumor-suppressor gene knockdown and oncogene activation.

Main Methods:

  • RNA sequencing (RNA-Seq) was performed on Drosophila wing disc epithelial tumors.
  • In vivo screens were conducted in sensitized genetic backgrounds to identify tumor-enhancing and tumor-suppressing miRNAs.
  • Comparative analysis was performed to identify evolutionarily conserved miRNAs with human homologs.

Main Results:

  • 51 mature miRNAs showed significant expression changes in tumorous discs.
  • 10 tumor-enhancing (TE) and 11 tumor-suppressing (TS) miRNAs were identified.
  • Four TE and three TS miRNAs possess human homologs, suggesting conserved functions.

Conclusions:

  • This study categorizes miRNAs based on their expression and functional relevance in epithelial tumorigenesis.
  • Evolutionarily conserved tumor-enhancing and tumor-suppressing miRNAs represent potential therapeutic targets for epithelial tumors.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K